Status:
COMPLETED
Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
65-75 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the reaction time (as measured by braking reaction time in seconds during simulated driving) under glare and no-glare conditions in subjects implanted with ACRY...
Detailed Description
Subjects completed 2 visits to the investigational site.
Eligibility Criteria
Inclusion
- Pseudophakes with ACRYSOF® IQ monofocal IOLs or clear (no blue light filter) IOLs in both eyes for at least 3 months.
- Willing and able to understand and sign an informed consent form.
- Corrected visual acuity (CVA) of 20/40 or better.
- Have a valid driver's license.
- Depth perception of at least 100 arc seconds.
- Other protocol-specified inclusion criteria may apply.
Exclusion
- Ocular pathology, degeneration, or media opacity.
- Color vision defect.
- Use of ocular or systemic medications that impact macular pigment density or reaction time, including but not limited to, lutein, zeaxanthin, barbiturates, tranquilizers or amphetamines.
- System conditions affecting connective tissue or sensory-motor coordination.
- Other protocol-specified exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02219997
Start Date
October 1 2014
End Date
March 1 2015
Last Update
May 26 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.